Back
Vigil Neuroscience 10K Form
Sell
27
VIGL
Vigil Neuroscience
Last Price:
3.43
Seasonality Move:
0.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VIGL News And Ratings
See the #1 stock for the next 7 days that we like better than VIGL
VIGL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-15.51M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.27 |
| Price / Book: | 1.6 |
Profitability
| EPS (TTM): | -2.12000 |
|---|---|
| Net Income (TTM): | $-83.84M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Vigil Neuroscience Earnings Forecast
Key Vigil Neuroscience Financial Ratios
- Per Share Earnings over the last 3 years have been positive in 1 years.
Vigil Neuroscience Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VIGL |
| Website: | vigilneuro.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VIGL Technical Analysis vs Fundamental Analysis
Sell
27
Vigil Neuroscience (VIGL)
is a Sell
Is Vigil Neuroscience a Buy or a Sell?
-
Vigil Neuroscience stock is rated a Sell
The current Vigil Neuroscience [VIGL] share price is $3.44. The Score for VIGL is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.